Our Why
Need to Address Clinical Data Gaps for Diverse Populations
Nearly 80% of new drugs approved annually lack sufficient clinical trials data to inform their safe and effective use in non-white patients despite advancements in medical research.
This data gap poses significant risks, as the routine use of unsafe or ineffective treatments in racial and ethnic can contribute to health disparities.
By Empowering Participation Built Upon Trust, We Can Drive Meaningful Change!
Nearly 80% of patients are likely to participate in a clinical trial if their doctor recommends it and finds the right trial for them.
Moreover, an overwhelming majority of Americans (87%) agree that healthcare professionals should discuss clinical trials with patients diagnosed with a disease as part of their standard of care.
Further, 61% agree that consideration of clinical trial participation should be a part of regular health care whether patients are healthy or ill.
Our Solutions
Training and Education
Training and Education
Training and Education
Physician Investigator Training:
Providing flexible comprehensive on-demand training programs for physicians to become skilled clinical trial investigators. This includes advanced courses for Good Clinical Practices certification and CME credits.
Cultural Considerations Training:
Offering on demand specialized training for physician-inv
Physician Investigator Training:
Providing flexible comprehensive on-demand training programs for physicians to become skilled clinical trial investigators. This includes advanced courses for Good Clinical Practices certification and CME credits.
Cultural Considerations Training:
Offering on demand specialized training for physician-investigators and their support personnel on cultural considerations in clinical trials to enhance patient engagement, participation, and retention.
Community Health Worker Training Program:
Establishing a training program for affiliated community health workers in communities served by physicians for the establishment of a support network; providing “Patient Navigators” to improve clinical trial patient engagement, featuring "TEA Talks" (Turning Education into Action) that offer practical, understandable information to patients from trusted sources.
Strategic Analysis
Training and Education
Training and Education
Physician and Patient Demographic Database: Creating a comprehensive database of physicians and de-identified patient demographics and disease characteristics. These aggregated, anonymized graphic data can be presented to industry sponsors to facilitate efficient site selection that optimizes for recruitment of a diverse participation.
Cl
Physician and Patient Demographic Database: Creating a comprehensive database of physicians and de-identified patient demographics and disease characteristics. These aggregated, anonymized graphic data can be presented to industry sponsors to facilitate efficient site selection that optimizes for recruitment of a diverse participation.
Clinical Trial Tracking and Alignment: Implementing a system to continuously track clinical trials that align with physician expertise and patient access, enabling targeted outreach to sponsors
Consulting Services
Training and Education
Consulting Services
Revenue Generation for Non-Investigator Physicians:
Creating opportunities for non-investigator physicians to serve as clinical trial “Physician Accelerators”, generating additional revenue streams.
Grant Acquisition Opportunities:
Assisting physician-investigators with identifying and securing clinical drug trial grants.
Customized Clinica
Revenue Generation for Non-Investigator Physicians:
Creating opportunities for non-investigator physicians to serve as clinical trial “Physician Accelerators”, generating additional revenue streams.
Grant Acquisition Opportunities:
Assisting physician-investigators with identifying and securing clinical drug trial grants.
Customized Clinical Trial Capabilities Development:
Leveraging our expertise and network to address your institution's needs in developing and expanding clinical trial capabilities.
Our Team
James Powell, M.D.
James Powell, M.D.
James Powell, M.D.
Dr. Powell is a graduate and former faculty member (Pharmacology) at Weill Cornell Medical College. He experienced 24 years as a clinical research executive in the biopharmaceutical industry. Powell is a former member of the Secretary’s (HHS) Advisory Committee on Human Research Protections, and PhRMA’s Clinical Trials Committee. He de
Dr. Powell is a graduate and former faculty member (Pharmacology) at Weill Cornell Medical College. He experienced 24 years as a clinical research executive in the biopharmaceutical industry. Powell is a former member of the Secretary’s (HHS) Advisory Committee on Human Research Protections, and PhRMA’s Clinical Trials Committee. He developed and directed The National Medical Association’s Project IMPACT that included training and education of hundreds of physicians to become clinical trial investigators and thousands of consumers and patients on the clinical trial process.
Brenda Conwell
James Powell, M.D.
James Powell, M.D.
Brenda, a seasoned clinical trials operations professional, brings 30+ years of experience to the field. Her expertise lies in strategically planning and managing Global Phase I-IV clinical trials across various therapeutic areas. Throughout her career, she has held leadership positions in clinical operations, demonstrating proficiency in
Brenda, a seasoned clinical trials operations professional, brings 30+ years of experience to the field. Her expertise lies in strategically planning and managing Global Phase I-IV clinical trials across various therapeutic areas. Throughout her career, she has held leadership positions in clinical operations, demonstrating proficiency in Good Clinical Practices, ethical considerations, and regulatory compliance related to human subject protection. Brenda’s background as a scientist at The Procter & Gamble Company underscores her commitment to advancing clinical research.
Ozan Karacagil
James Powell, M.D.
Ozan Karacagil
Ozan enjoyed a dynamic career with global companies like McDonald’s, Kearney, PwC, and with the startup SmartOps, working across the US, Germany, Japan, and Türkiye . Inspired by his parents, both medical doctors, he pursued his passion for healthcare by joining the Global Healthcare Leadership Program at Harvard Medical School. Ozan's e
Ozan enjoyed a dynamic career with global companies like McDonald’s, Kearney, PwC, and with the startup SmartOps, working across the US, Germany, Japan, and Türkiye . Inspired by his parents, both medical doctors, he pursued his passion for healthcare by joining the Global Healthcare Leadership Program at Harvard Medical School. Ozan's expertise spans strategy, finance, and supply chain. He holds an MBA from Carnegie Mellon University, where he attended on a full scholarship.